Publisert 28.06.2016

Canadian National Patent 2016

Canadian National Patent issued to Regenics' technology on June 28, 2016.

Regenics announces today that the Canadian Patent Office has issued a 20 year patent to Regenics on June 28, 2016. The patent expires May 5, 2031.

Canadian Patent no.: 2,798,137.
International Application no.: PCT/IB2011/001488.
International filing date:  May 5, 2011
Patent title: Use of fish egg extracts for cellular rejuvenation

For more information, contact CEO Henrik Lund 



Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.